Literature DB >> 3233287

Conformational role of His-12 in C-peptide of ribonuclease A.

M Dadlez1, A Bierzyński, A Godzik, M Sobocińska, G Kupryszewski.   

Abstract

Possible interactions of the His-12 ring with other side chain and backbone groups of C-peptide lactone (CPL) are discussed. The works published so far are critically reviewed and compared with the latest results obtained by the authors. The main new conclusion is that in the helical conformation of CPL, the Phe-8 and His-12 rings are clustered together. Studies of Phe-8----Ala analogs of CPL and calculations of ring current effects satisfactorily explain the observed environmental shifts of Phe-8 and His-12 protons in NMR spectra of CPL. Interaction between both rings is favorable for alpha-helix formation, but cannot explain an increase in helix stability related with protonation of His-12. This effect arises from favorable interactions of the charged His+-12 ring with the helix backbone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3233287     DOI: 10.1016/0301-4622(88)80023-1

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  4 in total

1.  Exploring atomistic details of pH-dependent peptide folding.

Authors:  Jana Khandogin; Jianhan Chen; Charles L Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

2.  Comparative Molecular Dynamics Analysis of RNase-S Complex Formation.

Authors:  Manuel P Luitz; Rainer Bomblies; Martin Zacharias
Journal:  Biophys J       Date:  2017-10-03       Impact factor: 4.033

3.  Structural studies of N-terminal mutants of connexin 32 using (1)H NMR spectroscopy.

Authors:  B D Kalmatsky; Y Batir; T A Bargiello; T L Dowd
Journal:  Arch Biochem Biophys       Date:  2012-06-14       Impact factor: 4.013

4.  Structural studies of the N-terminus of Connexin 32 using 1H NMR spectroscopy.

Authors:  B D Kalmatsky; S Bhagan; Q Tang; T A Bargiello; T L Dowd
Journal:  Arch Biochem Biophys       Date:  2009-07-26       Impact factor: 4.013

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.